Dairy intake after prostate cancer diagnosis in relation to disease‐specific and total mortality
Open Access
- 20 May 2015
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 137 (10) , 2462-2469
Abstract
Information regarding postdiagnostic dairy intake and prostate cancer survival is limited. We evaluated intake of total, high‐fat and low‐fat dairy after prostate cancer diagnosis in relation to disease‐specific and total mortality. We included 926 men from the Physicians’ Health Study diagnosed with non‐metastatic prostate cancer between 1982 and 2000 who completed a diet questionnaire a median of 5 years after diagnosis and were followed thereafter for a median of 10 years to assess mortality. Cox proportional hazards regression was used to estimate associations between dairy intake and prostate cancer specific and all‐cause mortality. During 8,903 person‐years of follow‐up, 333 men died, 56 due to prostate cancer. Men consuming ≥3 servings/day of total dairy products had a 76% higher risk of total mortality and a 141% higher risk of prostate cancer‐specific mortality compared to men who consumed less than 1 dairy product/day (hazard ratio (HR) = 1.76, 95% confidence interval (CI): 1.21, 2.55, ptrend < 0.001 for total mortality; HR = 2.41, 95% CI: 0.96, 6.02, ptrend = 0.04 for prostate cancer‐specific mortality). The association between high‐fat dairy and mortality risk appeared to be stronger than that of low‐fat dairy, but the difference between them was not statistically significant (p for difference = 0.57 for prostate cancer‐specific mortality and 0.56 for total mortality). Among men without metastases when diagnosed, higher intake of dairy foods after prostate cancer diagnosis may be associated with increased prostate cancer‐specific and all‐cause mortality.Keywords
Funding Information
- U.S. Department of War (W81XWH-11-1-0529)
- National Institutes of Health (CA42182, CA58684, CA90598, CA141298, CA97193, CA34944, CA40360, CA131945, P50CA90381, 1U54CA155626-01, P30DK046200, HL26490 and HL34595)
- Prostate Cancer Foundation
This publication has 44 references indexed in Scilit:
- Biochemical markers of bone turnover and clinical outcomes in men with prostate cancerUrologic Oncology: Seminars and Original Investigations, 2012
- Prognostic Role of Serum Parathyroid Hormone Levels in Advanced Prostate Cancer Patients Undergoing Zoledronic Acid AdministrationThe Oncologist, 2012
- Milk and Dairy Consumption among Men with Prostate Cancer and Risk of Metastases and Prostate Cancer DeathCancer Epidemiology, Biomarkers & Prevention, 2012
- Circulating Insulin-Like Growth Factors and IGF-Binding Proteins in PSA-Detected Prostate Cancer: The Large Case–Control Study ProtecTCancer Research, 2012
- Vitamins E and C in the Prevention of Prostate and Total Cancer in MenJAMA, 2009
- Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and NutritionBritish Journal of Cancer, 2008
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectivesJournal of Clinical Epidemiology, 1993
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992